BOC & Utrust Private Equity Fund Management
VC Fund
Guangzhou, China
BOC & Utrust Private Equity Fund Management is a private equity firm.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries BOC & Utrust Private Equity Fund Management invests in
Stages BOC & Utrust Private Equity Fund Management invests in
Countries BOC & Utrust Private Equity Fund Management invests in
Investment Focus
Industry
- Health Care 4 (31%)
- Biotechnology 4 (31%)
- Manufacturing 4 (31%)
- Pharmaceutical 3 (23%)
- Artificial Intelligence 3 (23%)
Stage
- Series C 5 (38%)
- Series B 4 (31%)
- Seed 2 (15%)
- Series A 2 (15%)
Country
- China 11 (85%)
- Switzerland 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Conmind Medical
|
Conmind Medical is a medical device company that provides safe, effective, and innovative neurointerventional and cardiac interventional medical devices. | $29.1M / Series C / Apr 07, 2026 | |
|
Shifeng Intelligent
|
Shifeng Intelligent Technology is a high-tech enterprise specializing in the manufacturing of intelligent equipment. | Seed / Feb 02, 2026 | |
Leman Biotech
|
Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies. | $28.8M / Series A / Jan 26, 2026 | |
|
Extreme Computing Technology
|
Extreme Computing Technology focuses on technology services such as artificial intelligence, the Internet of Things, and cloud computing. | Seed / Jan 19, 2026 | |
Zhilong New Materials
|
Zhilong New Materials is a Sino-foreign joint venture semiconductor material innovation enterprise that researches, produces, and sells semiconductor display sputtering targets and semiconductor photovoltaic targets. | Series A / Dec 31, 2024 | |
KingFocus Biomedical
|
Shenzhen based Biomedical Company. | Series C / Aug 28, 2024 | |
Sitan Technology
|
Sitan Technology is a technology enterprise specializing in the development, production, and sale of Micro-LED technology. | Series B / May 21, 2024 | |
Bostal Drug Delivery
|
Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems. The company provides pharmaceutical preparation technology platforms to develop innovative drugs, improve new drugs, and high-end generic drugs. It also offers preparation products technical development services for pharmaceutical companies.Thecompany was founded in 2013 and is headquartered in Guangzhou, Guangdong. | Series B / Aug 18, 2023 | |
ForChange
|
ForChange is an artificial intelligence online education company. | Series B / Apr 26, 2022 | |
Magpie Pharmaceuticals
|
Magpie Pharmaceuticals specialize in the research and development of first-in-class drugs. The company focuses on the structural modification and transformation of active natural product monomers in traditional Chinese medicines (TCM), as well as small molecular compounds currently in clinical use. | $14M / Series C / Apr 20, 2020 | |
| See all 13 investments → | |||
Co-Investors
Guangdong Technology Financial Group
3 deals together
BOCOM International
1 deal together
Canton Venture Capital
1 deal together
CCB International
1 deal together
China Cinda Asset Management
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BOC & Utrust Private Equity Fund Management invest in?
BOC & Utrust Private Equity Fund Management invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series C and Series B stage. Most of the 13 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did BOC & Utrust Private Equity Fund Management last invest?
The most recent investment recorded for BOC & Utrust Private Equity Fund Management closed in Apr 2026. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
